Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Biocity, Gigagen, Gritstone, Hitgen, Merck, Quris-AI, Scynexis.

Additional early-stage research and drug discovery news in brief, from: Enveric, Geneuro, Seelos, Theralase.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspekt Solutions, Everads Therapy, Femasys, Kriya Therapeutics, Nanovibronix, Onward Medical, Siemens Healthineers, Signati, Varian.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Adimab, Bayer, Caribou, Cellular, Cosmo, Coya, Everads, Evofem, Evommune, Galecto, Glenmark, Harmony, Imidomics, Indivior, Ionis, Kriya, Ligand, Maruho, Nektar, Novan, Omniose, Oncolytics, Ono, Padagis, Pathios, Proqr, Roche, Thea, Tonix, Twist, Zynerba.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: 1st Biotherapeutics, Beigene, Cerecin, Dyadic, Fermbox, Novartis.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amphista, AN2, Arcturus, Beactica, Biogen, BMS, Byorna, CGA 369, Dyadic, Evotec, Geovax, Liminal, Mediwound, Novo Nordisk, Oncopeptides, Probiogen, Reata, Sohm, Spinogenix, Sygnature, Synfini, Thea, Theradaptive, Theratechnologies, Trethera, Ube, Ultragenyx.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biomerica, Bio-Techne, Cardiosense, Clario, Galen Robotics, Mediwound, Satio, Senseonics, Spinex, Thermo Fisher, Viz.ai, Zimvie Inc.

Additional early-stage research and drug discovery news in brief, from: Transcode Therapeutics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Enovis, Limacorporate, Orion Health, Pieces Technologies, Veradigm, Vicarious Surgical.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biogen, Biophytis SA, Decibel, Eledon, Glycotype, MC2, Mitochem, Novartis, Pfizer, Pierre Fabre, Reata, Regeneron, Regranion, Sandoz, Skyepharma, South Rampart, Valneva, Vernalis.